Physician profile
Malika Singh
NPI 1386878445
$956.28
in general payments reported to CMS, 2019-2025
16 companies · $160 in 2025
The $160 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $391 · 2020: $161 · 2022: $122 · 2023: $122 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $281.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $295.03 | 2019-2022 | |
| Medtronic, INC. | $147.29 | 2023-2025 | Minimed 780g |
| Ascensia Diabetes Care US INC. | $82.57 | 2025 | |
| Companion Medical, INC. | $59.06 | 2020 | |
| Abbott Laboratories | $55.41 | 2022 | |
| Pfizer INC. | $53.88 | 2019 | |
| Insulet Corporation | $50.21 | 2019-2025 | Omnipod |
| Celgene Corporation | $39.86 | 2019 | |
| Sanofi-Aventis U.S. LLC | $36.61 | 2019-2020 | |
| Lilly USA, LLC | $23.92 | 2020 | |
| Alexion Pharmaceuticals, INC. | $23.11 | 2022 | |
| Dexcom, INC. | $22.43 | 2023 | Dexcom G6 Transmitter |
| Amgen INC. | $20.06 | 2020 | |
| Merck Sharp & Dohme LLC | $19.32 | 2019 | |
| Mannkind Corporation | $15.60 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malika Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.